Cargando…
Assessing the quality of life in age-related macular degeneration patients: A cross-sectional study in Kazakhstan
AIM: The goal of this study was to assess Vision-Related Quality of Life (VRQoL) in patients with Age-Related Macular Degeneration (AMD) and identify its significant predictors. METHODS: 458 AMD patients from four eye clinics in three major cities of Kazakhstan were recruited for this study. Data we...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828926/ https://www.ncbi.nlm.nih.gov/pubmed/36533748 http://dx.doi.org/10.23750/abm.v93i6.13580 |
_version_ | 1784867369884057600 |
---|---|
author | Ismayilova, Inara Turdaliyeva, Botagoz Aldasheva, Neilya Veselovskaya, Natalia |
author_facet | Ismayilova, Inara Turdaliyeva, Botagoz Aldasheva, Neilya Veselovskaya, Natalia |
author_sort | Ismayilova, Inara |
collection | PubMed |
description | AIM: The goal of this study was to assess Vision-Related Quality of Life (VRQoL) in patients with Age-Related Macular Degeneration (AMD) and identify its significant predictors. METHODS: 458 AMD patients from four eye clinics in three major cities of Kazakhstan were recruited for this study. Data were collected using a structured questionnaire on sociodemographic and visual information and the National Eye Institute-Visual Function Questionnaire-39 (NEI-VFQ-39). RESULTS: The study sample included 181 male patients who were 64.9 years on average (SD±8.4), and 277 female patients who were 68.7 years on average (SD±10.7). The majority of patients had stage 2 (43.7%) or stage 3 (40.2%) AMD according to the Age-Related Eye Disease Study (AREDS) classification. The mean (SD) NEI-VFQ-39 total score was 58.0 (23.8), range (9.8 - 100). The multiple linear regression model showed that the VRQoL of AMD patients correlated with the AMD stage according to the AREDS classification, age of the patients, visual acuity, number of years since the AMD diagnosis, and the city of residence. CONCLUSIONS: AMD causes severe vision impairment and daily functioning problems, reducing the quality of life of patients. To diagnose and treat degenerative eye disorders at an early stage, it is essential to inform patients about regular ophthalmological checkups to diagnose and treat degenerative eye disorders at an early stage. (www.actabiomedica.it) |
format | Online Article Text |
id | pubmed-9828926 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Mattioli 1885 |
record_format | MEDLINE/PubMed |
spelling | pubmed-98289262023-01-19 Assessing the quality of life in age-related macular degeneration patients: A cross-sectional study in Kazakhstan Ismayilova, Inara Turdaliyeva, Botagoz Aldasheva, Neilya Veselovskaya, Natalia Acta Biomed Original Article AIM: The goal of this study was to assess Vision-Related Quality of Life (VRQoL) in patients with Age-Related Macular Degeneration (AMD) and identify its significant predictors. METHODS: 458 AMD patients from four eye clinics in three major cities of Kazakhstan were recruited for this study. Data were collected using a structured questionnaire on sociodemographic and visual information and the National Eye Institute-Visual Function Questionnaire-39 (NEI-VFQ-39). RESULTS: The study sample included 181 male patients who were 64.9 years on average (SD±8.4), and 277 female patients who were 68.7 years on average (SD±10.7). The majority of patients had stage 2 (43.7%) or stage 3 (40.2%) AMD according to the Age-Related Eye Disease Study (AREDS) classification. The mean (SD) NEI-VFQ-39 total score was 58.0 (23.8), range (9.8 - 100). The multiple linear regression model showed that the VRQoL of AMD patients correlated with the AMD stage according to the AREDS classification, age of the patients, visual acuity, number of years since the AMD diagnosis, and the city of residence. CONCLUSIONS: AMD causes severe vision impairment and daily functioning problems, reducing the quality of life of patients. To diagnose and treat degenerative eye disorders at an early stage, it is essential to inform patients about regular ophthalmological checkups to diagnose and treat degenerative eye disorders at an early stage. (www.actabiomedica.it) Mattioli 1885 2022 2022-12-16 /pmc/articles/PMC9828926/ /pubmed/36533748 http://dx.doi.org/10.23750/abm.v93i6.13580 Text en Copyright: © 2022 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License |
spellingShingle | Original Article Ismayilova, Inara Turdaliyeva, Botagoz Aldasheva, Neilya Veselovskaya, Natalia Assessing the quality of life in age-related macular degeneration patients: A cross-sectional study in Kazakhstan |
title | Assessing the quality of life in age-related macular degeneration patients: A cross-sectional study in Kazakhstan |
title_full | Assessing the quality of life in age-related macular degeneration patients: A cross-sectional study in Kazakhstan |
title_fullStr | Assessing the quality of life in age-related macular degeneration patients: A cross-sectional study in Kazakhstan |
title_full_unstemmed | Assessing the quality of life in age-related macular degeneration patients: A cross-sectional study in Kazakhstan |
title_short | Assessing the quality of life in age-related macular degeneration patients: A cross-sectional study in Kazakhstan |
title_sort | assessing the quality of life in age-related macular degeneration patients: a cross-sectional study in kazakhstan |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828926/ https://www.ncbi.nlm.nih.gov/pubmed/36533748 http://dx.doi.org/10.23750/abm.v93i6.13580 |
work_keys_str_mv | AT ismayilovainara assessingthequalityoflifeinagerelatedmaculardegenerationpatientsacrosssectionalstudyinkazakhstan AT turdaliyevabotagoz assessingthequalityoflifeinagerelatedmaculardegenerationpatientsacrosssectionalstudyinkazakhstan AT aldashevaneilya assessingthequalityoflifeinagerelatedmaculardegenerationpatientsacrosssectionalstudyinkazakhstan AT veselovskayanatalia assessingthequalityoflifeinagerelatedmaculardegenerationpatientsacrosssectionalstudyinkazakhstan |